0 results for 'US Securities and Exchange Commission'
Generic Drugmaker Settles Claims for $500 Mil. With DOJ
A team of Venable attorneys represented drugmaker Ranbaxy USA Inc. in a $500 million settlement with the U.S. Department of Justice, marking one of the biggest drug safety deals ever with a generic-drug manufacturer.Georgia Courts in Dire Need of Tech Overhaul, Report Says
Technology upgrades are desperately needed to synchronize a disjointed court information system, according to a long-awaited report released Tuesday to the Georgia Supreme Court. The report, a year in the making, concluded that widening gaps in technology have prevented the state's more than 1,100 trial courts from creating a statewide or even a circuitwide system that allows criminal data to be shared electronically, possibly compromising public safety and homeland security.What's the 'Coolest' Product From LegalTech New York?
Shortly after LegalTech New York, LTN Technology Editor Sean Doherty was asked what the "coolest" thing was that he saw at the show. Although legal technology is not designed with a "cool" factor, Doherty recounts some practical new tools.View more book results for the query "US Securities and Exchange Commission"
Law Graduates and Deans Facing Major Transitions
AS LAW students and professors around the state celebrate the end of the academic year with commencement ceremonies, three law school deans will be officially donning their caps and gowns for the last time.Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)
Notice to the bar.Challenges to Corporate Control: Is Your Company Prepared?
Although a challenge to corporate control may not be a viable threat in the minds of corporate CEOs and general counsel, it remains an ever present danger to a public company whose shares are undervalued by the marketplace. Public companies should review their takeover defenses to ensure that incumbent management and directors can make their case to stockholders, enabling them to make rational determinations about the corporation's future.Seven Firms Lead on $8.6 Billion Deal for Drugmaker Elan
Cadwalader, Fried Frank, Gibson Dunn, Morgan Lewis, Sullivan & Cromwell, and leading Irish firms A&L Goodbody and Dillon Eustace are advising on the $6.7 billion cash-and-stock sale of Dublin-based biotechnology company Elan to U.S. generic pharmaceutical firm Perrigo, which will also assume $1.9 billion of the Irish drugmaker's debt. The transaction marks the end of a months-long engagement by corporate and litigation lawyers at Cadwalader on Elan's behalf.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Unlocking the Power of Early Case Assessment Workflows
Brought to you by Integreon
Download Now
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now